MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer
Citations Over TimeTop 10% of 2014 papers
Abstract
MicroRNAs (miRNAs) present frequently altered expression in urologic cancers including prostate, bladder, and kidney cancer. The altered expression of miR-223 has been reported in cancers and other diseases in recent researches. MiR-223 is up-regulated in systemic lupus erythematosus and rheumatoid arthritis. In neoplastic diseases, miR-223 is proved to be up-expressed in plasma or serum and cancer tissues compared with normal tissues in pancreatic cancer, gastric cancer, et al. However, whether altered expression of miR-223 is associated with prostate cancer (PCa) and what it is potential functions in PCa remained unveiled. In this study, we firstly found miR-223-3p were up-regulated in prostate cancer tissues and then we study functional role of miR-223-3p in PCa using DU145, PC3 and LNCaP cell lines. Our data suggested that miR-223-3p might target gene SEPT6 and promoted the biological behavior of prostate cancer. Notably, we found increasing SEPT6 expression might reverse the biological activity induced by miR-223-3p, which might be a potential therapeutic target for PCa.
Related Papers
- → Antiproliferative effect of polyphenols and sterols of virgin argan oil on human prostate cancer cell lines(2006)83 cited
- Study of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy.(2015)
- → A comparative study on proteomics between LNCap and DU145 cells by quantitative detection and SELDI analysis(2008)2 cited
- Comparative gene expression related to the uptake of PET radiotracers in prostate cancer cell lines(2012)
- → Abstract 1581: Crosstalk of androgen sensitive prostate cancer cells and insensitive prostate cancer cells(2016)